<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX World Congress USA

Date and Venue TBC

Review the 2018 agenda

The LSX World Congress USA combines plenaries, workshops, panels, a two-track global investment showcase, fireside chats,  an IPO bootcamp and one-to-one meetings to give life science companies everything they need to enable more effective partnering, investment, planning and strategic growth.

The full agenda including up-to-date confirmed speakers, session content, timings and further information on the 1-2-1 partnering and networking and, satellite sessions is available on the brochure.
DOWNLOAD THE 2018 BROCHURE

Day 1 Wednesday 10th October 2018 - Plenary Track

09:00 KEYNOTE ADDRESS: CAPITAL MARKETS OUTLOOK

Marshall Smith, Co-Head of EMEA Healthcare, Goldman Sachs 

09:20 KEYNOTE FIRESIDE CHAT: A NEW MODEL FOR DISRUPTIVE VALUE CREATION: INSTITUTIONAL ENTREPRENEURIAL INNOVATION

Noubar Afeyan, Founder and CEO, Flagship Pioneering
Surani Fernando, Editor, North America, GlobalData Healthcare (moderator)

09:40 KEYNOTE PANEL: EARLIER DEALS, LARGER ROUNDS AND NEW CAPITAL: MACRO VENTURE TRENDS

Lewis Geffen, Co-Chair, Life Science and VC & Emerging Companies Practice, Mintz Levin (moderator)
Paulina Hill, Principal, Polaris Partners 
Dylan Morris
, Partner, CRV 
Christopher de Souza, Director, Broadview Ventures 

10:20 KEYNOTE PANEL: CHALLENGES AND OPPORTUNITIES FOR PHARMA BD IN 2019

Jerry Lee, Managing Director, Goldman Sachs (moderator) 
Nigel Sheail, Global Head of M&A and BD&L, Novartis
Doug Giordano, SVP Worldwide BD, Pfizer
Boris Zaitra, Global Head of M&A, Roche
Aradhana Sarin, SVP, Head of BD & Strategy, Alexion Pharmaceuticals
Paul Biondi, SVP, Strategy and Business Development, Bristol-Myers Squibb

11:00 NETWORKING BREAK

11:30 PANEL: REDEFINING EARLY SCIENCE: INVESTING EARLY AND INVESTING LONGER

Lewis Geffen, Co-Chair, Life Sciences and VC & Emerging Companies Practice, Mintz Levin (moderator)
Arjun Goyal, Co-Founder, Vida Ventures
Andrew Elbardissi, Principal, Deerfield 
Aaron Kantoff, Principal, Apple Tree Partners 
Brett Zbar, Managing Director, Foresite Capital Management 
Mark Chin, Investment Director, Arix Bioscience 

12:10 FIRESIDE CHAT: CONNECTING WITH CREATIVITY

Ivana Magovčević-Liebisch, EVP & Chief Business Officer, Ipsen
Surani Fernando, Editor, North America, GlobalData Healthcare (moderator)

12:30 PANEL: CVC’S AUGMENTATION OF EARLY STAGE INNOVATION

Asher Rubin, Global Head, Life Sciences Industry Group, Hogan Lovells (moderator)
Jason Hafler
, Senior Director of Investments, Sanofi Ventures
Alicia Irurzun-Lafitte, Principal, MS-Ventures 
James Kasuboski, Director, Boehringer Ingelheim Venture Fund USA
Michal Silverberg, Managing Director, Novartis Venture Fund 

13:10 NETWORKING LUNCH

14:10 PANEL: CULTIVATING THE FAST GROWERS CLUB; FROM LAUNCH TO MASSIVE FUNDRAISE

Rosemary Reilly, Partner, WilmerHale (moderator)
Todd Foley
, Managing Director, MPM Capital
Neil Exter, Partner, Third Rock Ventures
Alexandra Glucksmann, CEO, Cedilla Therapeutics
Jim Broderick, CEO, Palleon Pharmaceuticals
Philip Lee, COO and Co-Founder, Senti Biosciences

14:50 FIRESIDE CHAT: FOSTERING INNOVATION TO ACCELERATE COMPANY GROWTH

Chandra Ramanathan, Vice President & Head, East Coast Innovation Centre, Bayer
Surani Fernando, Editor, North America, GlobalData Healthcare (moderator)

15:10 PANEL: NOUGHTS AND CROSSOVERS; VALUATIONS, ROUND SIZES AND UNCONVENTIONAL CAPITAL SOURCES

Michael Margolis, Co-Head of Healthcare Investment Banking, Oppenheimer (moderator)
Giovanni Mariggi
, Partner, Medicxi
Philip Astley-Sparke, Venture Partner, Forbion Capital Partners

15:50 NETWORKING BREAK

16:20   ADDRESSING KEY CHALLENGES IN IMMUNO-ONCOLOGY COMBINATION TRIALS

Jai Balkissoon, VP, Immuno-Oncology Global Product Development, PPD Biotech

KEYNOTE FIRESIDE CHATS: 'ANATOMY OF...'

16.40 ANATOMY OF AN UPSIZED IPO

Geoff Mackay, CEO, AvroBio
Michael Fitzgerald, Managing Director, NASDAQ (moderator)

17:00   BUILDING A GENE THERAPY PORTFOLIO FOR SUCCESS

Pavan Cheruvu, CEO, Axovant
Donna LaVoie, President and CEO, LaVoieHealthScience (moderator)

17:20  ANATOMY OF A CLINICAL-STAGE ACQUISITION

Brian Pereira, CEO, Visterra
Paul Sagan, AVP, Investor Relations and Corporate Communications, LaVoieHealthScience (moderator)

17:40 EXECUTIVE NETWORKING RECEPTION

Day 2 Thursday 11th October 2018 - Plenary Track


09:00 KEYNOTE PANEL: PRICING, PATIENTS AND PAYMENTS; A VALUE-BASED APPROACH

Brian Rye, Sr. Health-Care Policy Analyst, Government Team, Bloomberg Intelligence (moderator)
Marianne Hamilton Lopez, Research Director of Value-Based Payment Reform, Duke-Margolis
Michael Sherman, SVP and Chief Medical Officer, Harvard Pilgrim Health Care
Bruce Leicher, SVP and General Council, Momenta Pharma
Bob Ward, Chairman and CEO, Eloxx Pharmaceuticals

09:40 FIRESIDE CHAT: FROM A POSITION OF GLOBAL LEADERSHIP IN GENOMICS TRIALS: WHAT’S NEXT(CODE)?

Rob Brainin, CEO, WuXI NextCODE
Steve Abrams, Partner, Global Life Sciences Leadership Team, Hogan Lovells (moderator)

10:00 KEYNOTE PANEL: DIGITAL THERAPEUTICS; REBOOTING THE TRADITIONAL PHARMA MODEL?

Kimberly Ha, Founder and CEO, KKH Advisors (moderator)
Russ Johannesson, CEO, Glooko 
Adam Kaufman, CEO, Canary Health 
Joris Van Dam, Head Digital Therapeutics, Novartis 
Eddie Martucci, CEO, Akili Interactive
David Benshoof Klein, CEO, Click Therapeutics

10:40 NETWORKING BREAK

11:10 PANEL: I, BIOTECH; AI IN HEALTHCARE

Kimberly Ha, Founder and CEO, KKH Advisors (moderator)
Dennis Grishin
, Co-Founder, Nebula Genomics
Niven Narain, CEO, BERG Health
Ed Addison, CEO, Cloud Pharmaceuticals
Sandy Li, Vice President, Baidu Ventures USA

11:50 PANEL: ANALYZE THIS...BIG DATA DRIVEN INNOVATION

Doug Russell, SVP & General Manager, LaVoieHealthScience (moderator)
Leila Pirhaji
, Founder and CEO, ReviveMed
Josh Mandel-Brehm, CEO, CAMP4 Therapeutics
Gini Desphande, Founder and CEO, NuMedii
Alex de Winter, Managing Director, GE Ventures
Janna Hutz, Senior Director, Head of Human Biology & Data Science, Eisai

12:30 PANEL: THE DIGITAL VALUE OF BLOCKCHAIN

Jay Goth, Managing Partner, Forentis Fund (moderator)
Chrissa McFarlane, CEO, Patientory
Joe Cawley, CSO, Encrypgen
Drew Volpe, Founding Partner, First Star Ventures

13:10 NETWORKING LUNCH

14:10 PANEL: SEEKING HIGH RETURNS WITH CANNABINOIDS

Terry O'Dwyer, Co-CEO, LSX (moderator)
Dean Petkanas
, CEO, Kannalife Sciences
Karan Wadhera, Managing Partner, Casa Verde Capital
Neil Mahapatra, Chairman, Oxford Cannabinoid Technologies
Greg Gorgas, CEO, Artelo Biosciences

14:50 PANEL: THE AGE OF LONGEVITY: GO LONG!

Terry O'Dwyer, Co-CEO, Longevity Leaders (moderator)
Scott Shandler
, CEO, Longevity Biotech 
George Church, Professor of Genetics, Harvard Medical School
Thomas Hughes, CEO, Navitor Pharmaceuticals

15:30 PANEL: GOING WITH YOUR GUT: COMMERCIALIZING THE MICROBIOME

Terry O'Dwyer, Co-CEO, LSX (moderator)
Mark Smith
, CEO, Finch Therapeutics
David Donabedian, CEO, AXIAL Biotherapeutics
Philip Strandwitz, CEO, HoloBiome
Todd Krueger, CEO, AOBiome
Sohang Chatterjee, CEO, EnBiome Therapeutics

16:10 NETWORKING BREAK AND 1-2-1 PARTNERING

17:00 CLOSE OF CONGRESS

 The full agenda including up-to-date confirmed speakers, session content, timings and further information on the 1-2-1 partnering and networking and, satellite sessions is available on the brochure, which is avaialble for download below:

DOWNLOAD THE 2018 BROCHURE